COVID-19
South African President Cyril Ramaphosa stresses that the coronavirus pandemic "demonstrates the need to accelerate the establishment of the BRICS vaccine research and development centre" in his country, during the online summit of BRICS countries chaired by Russia.
"The current experience demonstrates the need to accelerate the establishment of the BRICS vaccine research and development centre in South Africa as agreed in the 2018 Johannesburg declaration," Ramaphosa stressed.
According to the president, the clinical testing of the vaccines needs to include African citizens to ensure that the vaccines are appropriate for them.
South Africa is participating in several research initiatives with continental and international partners, including the global effort to develop, manufacture and distribute a #COVID19 vaccine. He futher stressed that Vaccine development must be encouraged, especially for pharmaceutical companies.
 
                                 
                                 
             
         
                                                                                 
                                                             
                                                             
                                                             
                                                             
                                                             
                                                                                 
                                                             
                                                            
01:14
Cholera surges globally as vaccine shortfalls and poverty fuel resurgence
00:31
RSF Commander admits "violations" after hundreds of civilians reportedly killed in el-Fasher
01:28
WHO leads first medical evacuations from Gaza Strip since ceasefire
01:49
mRNA Covid vaccines may boost cancer treatment, study finds
00:28
DRC begins countdown to end of Ebola outbreak as last patient recovers
Go to video
New HIV prevention injection rolls out to end new cases by 2030